Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 323

1.

Colorectal Adenomas and Cancers After Childhood Cancer Treatment: A DCOG-LATER Record Linkage Study.

Teepen JC, Kok JL, van Leeuwen FE, Tissing WJE, Dolsma WV, van der Pal HJ, Loonen JJ, Bresters D, Versluys B, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E, van den Berg MH, van der Heiden-van der Loo M, Hauptmann M, Jongmans MC, Overbeek LI, van de Vijver MJ, Kremer LCM, Ronckers CM; DCOG-LATER Study Group, Aleman BMP, van den Berg MH, Bresters D, Caron HN, Daniels LA, Dolsma W, van Dulmen-den Broeder E, Grootenhuis MA, Haasbeek CJ, den Hartogh JG, Hauptmann M, van der Heiden-van der Loo M, van den Heuvel-Eibrink MM, Hollema N, Janssens GO, Jongmans MC, Jaspers MWM, Kok JL, Kremer LCM, van Leeuwen FE, Loonen J, Maduro JH, Neggers SJCMM, Oldenburger F, Overbeek LI, van der Pal HJ, Postma A, de Ridder-Sluiter JG, van Rij CM, Ronckers CM, Teepen JC, Tersteeg RJ, Tissing WJE, Versluys AB, van de Vijver MJ, Zsíros J.

J Natl Cancer Inst. 2018 Jul 1;110(7):758-767. doi: 10.1093/jnci/djx266.

PMID:
29986097
2.

Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.

Oosterom N, Griffioen PH, den Hoed MAH, Pieters R, de Jonge R, Tissing WJE, van den Heuvel-Eibrink MM, Heil SG.

PLoS One. 2018 Jul 9;13(7):e0199574. doi: 10.1371/journal.pone.0199574. eCollection 2018.

3.

Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve.

van den Berg MH, Overbeek A, Lambalk CB, Kaspers GJL, Bresters D, van den Heuvel-Eibrink MM, Kremer LC, Loonen JJ, van der Pal HJ, Ronckers CM, Tissing WJE, Versluys AB, van der Heiden-van der Loo M, Heijboer AC, Hauptmann M, Twisk JWR, Laven JSE, Beerendonk CCM, van Leeuwen FE, van Dulmen-den Broeder E; DCOG LATER-VEVO study group.

Hum Reprod. 2018 Jul 6. doi: 10.1093/humrep/dey229. [Epub ahead of print]

PMID:
29982673
4.

Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.

Brok J, Lopez-Yurda M, Tinteren HV, Treger TD, Furtwängler R, Graf N, Bergeron C, van den Heuvel-Eibrink MM, Pritchard-Jones K, Olsen ØE, de Camargo B, Verschuur A, Spreafico F.

Lancet Oncol. 2018 Jun 27. pii: S1470-2045(18)30293-6. doi: 10.1016/S1470-2045(18)30293-6. [Epub ahead of print]

PMID:
29960848
5.

A decrease in vitamin D levels is associated with methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.

Oosterom N, Dirks NF, Heil SG, de Jonge R, Tissing WJE, Pieters R, van den Heuvel-Eibrink MM, Heijboer AC, Pluijm SMF.

Support Care Cancer. 2018 Jun 19. doi: 10.1007/s00520-018-4312-0. [Epub ahead of print]

PMID:
29922939
6.

Models of Care for Survivors of Childhood Cancer From Across the Globe: Advancing Survivorship Care in the Next Decade.

Tonorezos ES, Barnea D, Cohn RJ, Cypriano MS, Fresneau BC, Haupt R, Hjorth L, Ishida Y, Kruseova J, Kuehni CE, Kurkure PA, Langer T, Nathan PC, Skeen JE, Skinner R, Tacyildiz N, van den Heuvel-Eibrink MM, Winther JF, Hudson MM, Oeffinger KC.

J Clin Oncol. 2018 Jul 20;36(21):2223-2230. doi: 10.1200/JCO.2017.76.5180. Epub 2018 Jun 6.

PMID:
29874138
7.

Reproductive Function and Outcomes in Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Review.

van Dorp W, Haupt R, Anderson RA, Mulder RL, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E, Su HI, Falck Winther J, Hudson MM, Levine JM, Wallace WH.

J Clin Oncol. 2018 Jul 20;36(21):2169-2180. doi: 10.1200/JCO.2017.76.3441. Epub 2018 Jun 6.

PMID:
29874135
8.

The long non-coding RNA landscape in juvenile myelomonocytic leukemia.

Hofmans M, Lammens T, Helsmoortel HH, Bresolin S, Cavé H, Flotho C, Hasle H, van den Heuvel-Eibrink MM, Niemeyer C, Stary J, Van Roy N, Van Vlierberghe P, Philippé J, De Moerloose B.

Haematologica. 2018 Jun 1. pii: haematol.2018.189977. doi: 10.3324/haematol.2018.189977. [Epub ahead of print] No abstract available.

9.

Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014.

Teepen JC, Curtis RE, Dores GM, Berrington de Gonzalez A, van den Heuvel-Eibrink MM, Kremer LCM, Gilbert ES, van Leeuwen FE, Ronckers CM, Morton LM.

Leukemia. 2018 May 24. doi: 10.1038/s41375-018-0149-2. [Epub ahead of print]

PMID:
29795414
10.

The influence of genetic variation on late toxicities in childhood cancer survivors: A review.

Clemens E, van der Kooi ALF, Broer L, van Dulmen-den Broeder E, Visscher H, Kremer L, Tissing W, Loonen J, Ronckers CM, Pluijm SMF, Neggers SJCMM, Zolk O, Langer T, Zehnhoff-Dinnesen AA, Wilson CL, Hudson MM, Carleton B, Laven JSE, Uitterlinden AG, van den Heuvel-Eibrink MM.

Crit Rev Oncol Hematol. 2018 Jun;126:154-167. doi: 10.1016/j.critrevonc.2018.04.001. Epub 2018 Apr 12. Review.

PMID:
29759558
11.

Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 Registry.

Dávila Fajardo R, Oldenburger E, Rübe C, López-Yurda M, Pritchard-Jones K, Bergeron C, Graf N, van Grotel M, van Tinteren H, Saunders D, van den Heuvel-Eibrink MM, Janssens GO, Oldenburger F.

Pediatr Blood Cancer. 2018 Aug;65(8):e27085. doi: 10.1002/pbc.27085. Epub 2018 Apr 25.

PMID:
29693799
12.

RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML.

Cucchi DGJ, Denys B, Kaspers GJL, Janssen JJWM, Ossenkoppele GJ, de Haas V, Zwaan CM, van den Heuvel-Eibrink MM, Philippé J, Csikós T, Kwidama Z, de Moerloose B, de Bont ESJM, Lissenberg-Witte BI, Zweegman S, Verwer F, Vandepoele K, Schuurhuis GJ, Sonneveld E, Cloos J.

Blood. 2018 May 31;131(22):2485-2489. doi: 10.1182/blood-2017-12-819508. Epub 2018 Apr 18.

PMID:
29669779
13.

Reproductive intentions and use of reproductive health care among female survivors of childhood cancer.

van Dijk M, van den Berg MH, Overbeek A, Lambalk CB, van den Heuvel-Eibrink MM, Tissing WJ, Kremer LC, van der Pal HJ, Loonen JJ, Versluys B, Bresters D, Kaspers GJL, van Leeuwen FE, van Dulmen-den Broeder E; DCOG LATER-VEVO study group.

Hum Reprod. 2018 Jun 1;33(6):1167-1174. doi: 10.1093/humrep/dey058.

PMID:
29617794
14.

Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocol.

Gooskens SL, Graf N, Furtwängler R, Spreafico F, Bergeron C, Ramírez-Villar GL, Godzinski J, Rübe C, Janssens GO, Vujanic GM, Leuschner I, Coulomb-L'Hermine A, Smets AM, de Camargo B, Stoneham S, van Tinteren H, Pritchard-Jones K, van den Heuvel-Eibrink MM; International Society of Paediatric Oncology–Renal Tumour Study Group (SIOP–RTSG).

Nat Rev Urol. 2018 May;15(5):309-319. doi: 10.1038/nrurol.2018.14. Epub 2018 Feb 27. Review.

PMID:
29485128
15.

Intra- and inter-fraction uncertainties during IGRT for Wilms' tumor.

Guerreiro F, Seravalli E, Janssens GO, van de Ven CP, van den Heuvel-Eibrink MM, Raaymakers BW.

Acta Oncol. 2018 Feb 19:1-9. doi: 10.1080/0284186X.2018.1438655. [Epub ahead of print]

PMID:
29457751
16.

The distress thermometer provides a simple screening tool for selecting distressed childhood cancer survivors.

van der Geest IMM, van Dorp W, Pluijm SMF, van den Heuvel-Eibrink MM.

Acta Paediatr. 2018 May;107(5):871-874. doi: 10.1111/apa.14251. Epub 2018 Feb 27.

PMID:
29385290
17.

Health-related fitness in very long-term survivors of childhood cancer: A cross-sectional study.

Hartman A, Pluijm SMF, Wijnen M, Neggers SJCMM, Clemens E, Pieters R, van den Heuvel-Eibrink MM.

Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26907. Epub 2017 Dec 22.

PMID:
29271565
18.

RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.

Lipka DB, Witte T, Toth R, Yang J, Wiesenfarth M, Nöllke P, Fischer A, Brocks D, Gu Z, Park J, Strahm B, Wlodarski M, Yoshimi A, Claus R, Lübbert M, Busch H, Boerries M, Hartmann M, Schönung M, Kilik U, Langstein J, Wierzbinska JA, Pabst C, Garg S, Catalá A, De Moerloose B, Dworzak M, Hasle H, Locatelli F, Masetti R, Schmugge M, Smith O, Stary J, Ussowicz M, van den Heuvel-Eibrink MM, Assenov Y, Schlesner M, Niemeyer C, Flotho C, Plass C.

Nat Commun. 2017 Dec 19;8(1):2126. doi: 10.1038/s41467-017-02177-w.

19.

Psychosocial development in survivors of childhood differentiated thyroid carcinoma: a cross-sectional study.

Nies M, Dekker BL, Sulkers E, Huizinga GA, Klein Hesselink MS, Maurice-Stam H, Grootenhuis MA, Brouwers AH, Burgerhof JGM, van Dam EWCM, Havekes B, van den Heuvel-Eibrink MM, Corssmit EPM, Kremer LCM, Netea-Maier RT, van der Pal HJH, Peeters RP, Plukker JTM, Ronckers CM, van Santen HM, van der Horst-Schrivers ANA, Tissing WJE, Bocca G, Links TP.

Eur J Endocrinol. 2018 Mar;178(3):215-223. doi: 10.1530/EJE-17-0741. Epub 2017 Dec 18.

20.

Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium.

Clement SC, Kremer LCM, Verburg FA, Simmons JH, Goldfarb M, Peeters RP, Alexander EK, Bardi E, Brignardello E, Constine LS, Dinauer CA, Drozd VM, Felicetti F, Frey E, Heinzel A, van den Heuvel-Eibrink MM, Huang SA, Links TP, Lorenz K, Mulder RL, Neggers SJ, Nieveen van Dijkum EJM, Oeffinger KC, van Rijn RR, Rivkees SA, Ronckers CM, Schneider AB, Skinner R, Wasserman JD, Wynn T, Hudson MM, Nathan PC, van Santen HM.

Cancer Treat Rev. 2018 Feb;63:28-39. doi: 10.1016/j.ctrv.2017.11.005. Epub 2017 Nov 14. Review.

PMID:
29202445
21.

Diastolic Dysfunction is Common in Survivors of Pediatric Differentiated Thyroid Carcinoma.

Klein Hesselink MS, Bocca G, Hummel YM, Brouwers AH, Burgerhof JGM, van Dam EWCM, Gietema JA, Havekes B, van den Heuvel-Eibrink MM, Corssmit EPM, Kremer LCM, Netea-Maier RT, van der Pal HJH, Peeters RP, Plukker JTM, Ronckers CM, van Santen HM, van der Meer P, Links TP, Tissing WJE.

Thyroid. 2017 Dec;27(12):1481-1489. doi: 10.1089/thy.2017.0383.

PMID:
29132262
22.

Targeting acute myeloid leukemia by drug-induced c-MYB degradation.

Walf-Vorderwülbecke V, Pearce K, Brooks T, Hubank M, van den Heuvel-Eibrink MM, Zwaan CM, Adams S, Edwards D, Bartram J, Samarasinghe S, Ancliff P, Khwaja A, Goulden N, Williams G, de Boer J, Williams O.

Leukemia. 2018 Apr;32(4):882-889. doi: 10.1038/leu.2017.317. Epub 2017 Nov 1.

PMID:
29089643
23.

Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.

van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, van Tinteren H, Furtwängler R, Verschuur AC, Vujanic GM, Leuschner I, Brok J, Rübe C, Smets AM, Janssens GO, Godzinski J, Ramírez-Villar GL, de Camargo B, Segers H, Collini P, Gessler M, Bergeron C, Spreafico F, Graf N; International Society of Paediatric Oncology — Renal Tumour Study Group (SIOP–RTSG).

Nat Rev Urol. 2017 Dec;14(12):743-752. doi: 10.1038/nrurol.2017.163. Epub 2017 Oct 31. Review.

PMID:
29089605
24.

TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration.

Gooskens SL, Klasson TD, Gremmels H, Logister I, Pieters R, Perlman EJ, Giles RH, van den Heuvel-Eibrink MM.

Mol Oncol. 2018 Feb;12(2):166-179. doi: 10.1002/1878-0261.12149. Epub 2017 Dec 14.

25.

Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group.

Hol JA, van den Heuvel-Eibrink MM, Graf N, Pritchard-Jones K, Brok J, van Tinteren H, Howell L, Verschuur A, Bergeron C, Kager L, Catania S, Spreafico F, Mavinkurve-Groothuis AMC.

Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26849. Epub 2017 Oct 27.

PMID:
29077255
26.

Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study.

Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen JAMJL, van der Lely AJ, Johannsson G, Neggers SJCMM.

Eur J Endocrinol. 2018 Jan;178(1):95-104. doi: 10.1530/EJE-17-0707. Epub 2017 Oct 18.

PMID:
29046325
27.

MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.

Larmonie NSD, Arentsen-Peters TCJM, Obulkasim A, Valerio D, Sonneveld E, Danen-van Oorschot AA, de Haas V, Reinhardt D, Zimmermann M, Trka J, Baruchel A, Pieters R, van den Heuvel-Eibrink MM, Zwaan CM, Fornerod M.

Oncogene. 2018 Jan 4;37(1):107-115. doi: 10.1038/onc.2017.293. Epub 2017 Sep 11.

PMID:
28892045
28.

The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up.

Wijnen M, Olsson DS, van den Heuvel-Eibrink MM, Hammarstrand C, Janssen JAMJL, van der Lely AJ, Johannsson G, Neggers SJCMM.

Eur J Endocrinol. 2018 Jan;178(1):11-22. doi: 10.1530/EJE-17-0387. Epub 2017 Sep 7.

PMID:
28882980
29.

Frequency and characteristics of pulmonary nodules in children at computed tomography.

Samim A, Littooij AS, van den Heuvel-Eibrink MM, Wessels FJ, Nievelstein RAJ, de Jong PA.

Pediatr Radiol. 2017 Dec;47(13):1751-1758. doi: 10.1007/s00247-017-3946-2. Epub 2017 Sep 4.

30.

C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation.

Marneth AE, Prange KHM, Al Hinai ASA, Bergevoet SM, Tesi N, Janssen-Megens EM, Kim B, Sharifi N, Yaspo ML, Kuster J, Sanders MA, Stoetman ECG, Knijnenburg J, Arentsen-Peters TCJM, Zwaan CM, Stunnenberg HG, van den Heuvel-Eibrink MM, Haferlach T, Fornerod M, Jansen JH, Valk PJM, van der Reijden BA, Martens JHA.

Leukemia. 2018 Mar;32(3):828-836. doi: 10.1038/leu.2017.280. Epub 2017 Sep 5.

PMID:
28871137
31.

Very Long-term Sequelae After Nonradical Surgery Combined With Brachytherapy in an Infant With a Chemotherapy-resistant Rhabdomyosarcoma of the Tongue.

van Rijswijk PM, van den Heuvel-Eibrink MM, van den Akker ELT, Slagter C, Lequin MH, Aarsen FK, van Atteveld JE, Wagner A, van Grotel M.

J Pediatr Hematol Oncol. 2017 Oct;39(7):566-569. doi: 10.1097/MPH.0000000000000935.

PMID:
28859029
32.

The MLL recombinome of acute leukemias in 2017.

Meyer C, Burmeister T, Gröger D, Tsaur G, Fechina L, Renneville A, Sutton R, Venn NC, Emerenciano M, Pombo-de-Oliveira MS, Barbieri Blunck C, Almeida Lopes B, Zuna J, Trka J, Ballerini P, Lapillonne H, De Braekeleer M, Cazzaniga G, Corral Abascal L, van der Velden VHJ, Delabesse E, Park TS, Oh SH, Silva MLM, Lund-Aho T, Juvonen V, Moore AS, Heidenreich O, Vormoor J, Zerkalenkova E, Olshanskaya Y, Bueno C, Menendez P, Teigler-Schlegel A, Zur Stadt U, Lentes J, Göhring G, Kustanovich A, Aleinikova O, Schäfer BW, Kubetzko S, Madsen HO, Gruhn B, Duarte X, Gameiro P, Lippert E, Bidet A, Cayuela JM, Clappier E, Alonso CN, Zwaan CM, van den Heuvel-Eibrink MM, Izraeli S, Trakhtenbrot L, Archer P, Hancock J, Möricke A, Alten J, Schrappe M, Stanulla M, Strehl S, Attarbaschi A, Dworzak M, Haas OA, Panzer-Grümayer R, Sedék L, Szczepański T, Caye A, Suarez L, Cavé H, Marschalek R.

Leukemia. 2018 Feb;32(2):273-284. doi: 10.1038/leu.2017.213. Epub 2017 Jul 13.

33.

Apparent diffusion coefficient as it relates to histopathology findings in post-chemotherapy nephroblastoma: a feasibility study.

Littooij AS, Nikkels PG, Hulsbergen-van de Kaa CA, van de Ven CP, van den Heuvel-Eibrink MM, Olsen ØE.

Pediatr Radiol. 2017 Nov;47(12):1608-1614. doi: 10.1007/s00247-017-3931-9. Epub 2017 Jul 1.

34.

The miR-1206 microRNA variant is associated with methotrexate-induced oral mucositis in pediatric acute lymphoblastic leukemia.

Gutierrez-Camino A, Oosterom N, den Hoed MAH, Lopez-Lopez E, Martin-Guerrero I, Pluijm SMF, Pieters R, de Jonge R, Tissing WJE, Heil SG, García-Orad A, van den Heuvel-Eibrink MM.

Pharmacogenet Genomics. 2017 Aug;27(8):303-306. doi: 10.1097/FPC.0000000000000291.

PMID:
28628559
35.

Eating behavior during dexamethasone treatment in children with acute lymphoblastic leukemia.

Warris LT, van den Akker ELT, Bierings MB, van den Bos C, Aarsen FK, Zwaan MC, Tissing WJE, Veening MA, Pieters R, van den Heuvel-Eibrink MM.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26679. Epub 2017 Jun 9.

PMID:
28598548
36.

Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.

Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Pal HJ, Loonen JJ, Bresters D, Versluys B, Neggers SJCMM, Jaspers MWM, Hauptmann M, van der Heiden-van der Loo M, Visser O, Kremer LCM, Ronckers CM; DCOG LATER Study Group.

J Clin Oncol. 2017 Jul 10;35(20):2288-2298. doi: 10.1200/JCO.2016.71.6902. Epub 2017 May 22.

PMID:
28530852
37.

Demodicosis in Pediatric Cancer.

van Atteveld JE, Graaf M, Grotel MV, van den Heuvel-Eibrink MM.

J Pediatr Hematol Oncol. 2017 Jul;39(5):402-406. doi: 10.1097/MPH.0000000000000836.

PMID:
28486260
38.

Recurrently affected genes in juvenile myelomonocytic leukaemia.

Obenauer JC, Kavelaars FG, Sanders MA, de Vries ACH, de Haas V, Beverloo HB, De Moerloose B, Lammens T, Dworzak M, Hoogenboezem RM, Valk PJM, Touw IP, van den Heuvel-Eibrink MM.

Br J Haematol. 2018 Jul;182(1):135-138. doi: 10.1111/bjh.14737. Epub 2017 May 9. No abstract available.

PMID:
28485469
39.

Feeding strategies in pediatric cancer patients with gastrointestinal mucositis: a multicenter prospective observational study and international survey.

Kuiken NSS, Rings EHHM, van den Heuvel-Eibrink MM, van de Wetering MD, Tissing WJE.

Support Care Cancer. 2017 Oct;25(10):3075-3083. doi: 10.1007/s00520-017-3715-7. Epub 2017 Apr 26.

40.

Classification of pediatric acute myeloid leukemia based on miRNA expression profiles.

Obulkasim A, Katsman-Kuipers JE, Verboon L, Sanders M, Touw I, Jongen-Lavrencic M, Pieters R, Klusmann JH, Michel Zwaan C, van den Heuvel-Eibrink MM, Fornerod M.

Oncotarget. 2017 May 16;8(20):33078-33085. doi: 10.18632/oncotarget.16525.

41.

RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131-I-metaiodobenzylguanidine. Huibregtse K et al. European Journal of Cancer 2016. 66:144-152.

Ronckers CM, Tytgat L, van den Heuvel-Eibrink MM, Teepen J, Kremer LCM, Clement S, van Santen HM.

Eur J Cancer. 2017 May;77:21-23. doi: 10.1016/j.ejca.2017.02.019. Epub 2017 Mar 27. No abstract available.

PMID:
28359832
42.

Very long-term sequelae of craniopharyngioma.

Wijnen M, van den Heuvel-Eibrink MM, Janssen JAMJL, Catsman-Berrevoets CE, Michiels EMC, van Veelen-Vincent MC, Dallenga AHG, van den Berge JH, van Rij CM, van der Lely AJ, Neggers SJCMM.

Eur J Endocrinol. 2017 Jun;176(6):755-767. doi: 10.1530/EJE-17-0044. Epub 2017 Mar 21.

43.

Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium.

Skinner R, Mulder RL, Kremer LC, Hudson MM, Constine LS, Bardi E, Boekhout A, Borgmann-Staudt A, Brown MC, Cohn R, Dirksen U, Giwercman A, Ishiguro H, Jahnukainen K, Kenney LB, Loonen JJ, Meacham L, Neggers S, Nussey S, Petersen C, Shnorhavorian M, van den Heuvel-Eibrink MM, van Santen HM, Wallace WH, Green DM.

Lancet Oncol. 2017 Feb;18(2):e75-e90. doi: 10.1016/S1470-2045(17)30026-8. Review. Erratum in: Lancet Oncol. 2017 Apr;18(4):e196.

PMID:
28214419
44.

Congenital mesoblastic nephroma 50 years after its recognition: A narrative review.

Gooskens SL, Houwing ME, Vujanic GM, Dome JS, Diertens T, Coulomb-l'Herminé A, Godzinski J, Pritchard-Jones K, Graf N, van den Heuvel-Eibrink MM.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26437. Epub 2017 Jan 26. Review.

PMID:
28124468
45.

Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.

de Rooij JD, Branstetter C, Ma J, Li Y, Walsh MP, Cheng J, Obulkasim A, Dang J, Easton J, Verboon LJ, Mulder HL, Zimmermann M, Koss C, Gupta P, Edmonson M, Rusch M, Lim JY, Reinhardt K, Pigazzi M, Song G, Yeoh AE, Shih LY, Liang DC, Halene S, Krause DS, Zhang J, Downing JR, Locatelli F, Reinhardt D, van den Heuvel-Eibrink MM, Zwaan CM, Fornerod M, Gruber TA.

Nat Genet. 2017 Mar;49(3):451-456. doi: 10.1038/ng.3772. Epub 2017 Jan 23.

46.

Validation of a clinical screening instrument for tumour predisposition syndromes in patients with childhood cancer (TuPS): protocol for a prospective, observational, multicentre study.

Postema FA, Hopman SM, de Borgie CA, Hammond P, Hennekam RC, Merks JH; TuPS study group, Aalfs CM, Anninga JK, Berger LP, Bleeker FE, de Bont ES, de Borgie CA, Dommering CJ, van Eijkelenburg NK, Hammond P, Hennekam RC, van den Heuvel-Eibrink MM, Hopman SM, Jongmans MC, Kors WA, Letteboer TG, Loeffen JL, Merks JH, Olderode-Berends MJ, Postema FA, Wagner A; TuPS study group.

BMJ Open. 2017 Jan 20;7(1):e013237. doi: 10.1136/bmjopen-2016-013237.

47.

Home-Based Palliative Care for Children With Incurable Cancer: Long-term Perspectives of and Impact on General Practitioners.

van der Geest IM, Bindels PJ, Pluijm SM, Michiels EM, van der Heide A, Pieters R, Darlington AE, van den Heuvel-Eibrink MM.

J Pain Symptom Manage. 2017 Mar;53(3):578-587. doi: 10.1016/j.jpainsymman.2016.09.012. Epub 2016 Dec 29.

PMID:
28042078
48.

Long-Term Quality of Life in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma.

Nies M, Klein Hesselink MS, Huizinga GA, Sulkers E, Brouwers AH, Burgerhof JGM, van Dam EWCM, Havekes B, van den Heuvel-Eibrink MM, Corssmit EPM, Kremer LCM, Netea-Maier RT, van der Pal HJH, Peeters RP, Plukker JTM, Ronckers CM, van Santen HM, Tissing WJE, Links TP, Bocca G.

J Clin Endocrinol Metab. 2017 Apr 1;102(4):1218-1226. doi: 10.1210/jc.2016-2246.

PMID:
28001468
49.

Biology and treatment of renal tumours in childhood.

Brok J, Treger TD, Gooskens SL, van den Heuvel-Eibrink MM, Pritchard-Jones K.

Eur J Cancer. 2016 Oct 28;68:179-195. doi: 10.1016/j.ejca.2016.09.005. [Epub ahead of print] Review.

50.

Paediatric renal tumours: perspectives from the SIOP-RTSG.

SIOP Renal Tumour Study Group.

Nat Rev Urol. 2017 Jan;14(1):3-4. doi: 10.1038/nrurol.2016.247. Epub 2016 Dec 6.

PMID:
27922041

Supplemental Content

Loading ...
Support Center